The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version
The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Abstract
The objective of this study was to test the reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30). The English-language version of the questionnaire was translated into Persian (Iranian language), and its final form was approved by the EORTC Study Group on Quality of Life before it was used in this study. The questionnaire was administered at two time points to a consecutive sample of 168 newly diagnosed breast cancer patients, and almost all of them (99%) found the questions easy to understand and acceptable. Crohnbach's alpha coefficient for multi-item scales (to test reliability) ranged from 0.48 to 0.95 at baseline and from 0.52 to 0.98 at follow-up administration of the questionnaire. Validity was checked using two methods: inter-scale correlation and known-groups comparison. Almost all inter-scale correlations were statistically significant in the expected direction. Known-groups comparison analysis showed that all functioning and symptom scales discriminated between subgroups of patients differing in clinical status as defined by their performance status and disease stage. In general, the findings of this study indicate that the Iranian version of the EORTC QLQ-C30 is a reliable and valid measure of quality of life in cancer patients and can be used in clinical trials and studies of outcome research in oncology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, the Persian version of QOL of Cancer Patients (QLQ-C30) was previously validated in Iranian patients (Cronbach α for its subscales measured from 0.48 to 0.89).27”
From A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression (2024) · cites this paper as [27]
Citations
Cites
Coefficient Alpha and the Internal Structure of Tests
Cronbach, L. J. (1951) · Psychometrika · doi:10.1007/bf02310555 · Cited by 43,931 · cited 1×
“The internal consistency of the multi-item scales was assessed by Cronbach’s alpha coefficient [10].”
MethodAaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005 · cited 14×
“It is argued that the best developed quality of life measure for use with cancer patients is currently the EORTC QLQ-C30 [6].”
BackgroundMethodResultInfluentialFoundations of Behavioral Research
Stockton, R., & Kerlinger, F. N. (1974) · American Educational Research Journal · doi:10.2307/1162206 · Cited by 7,347 · cited 1×
“Second, the method of known-groups comparison was used to evaluate the extent to which the QLQ-C30 was able to discriminate between subgroups of patients differing in clinical status [ 16 ].”
MethodA Critical Appraisal of the Quality of Quality-of-Life Measurements
Gill, T. M. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520080061045 · Cited by 2,208
Brady, M. J., Cella, D. F., Mo, F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., Deasy, S., Cobleigh, M., & Shiomoto, G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.974 · Cited by 1,752
Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., Franzini, L., Williams, A., de Haes, H. C., Hopwood, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2756 · Cited by 1,220 · cited 1×
“Despite the cultural differences that exist between Europe and Asia, in our centre (Iranian Centre for Breast Cancer-ICBC) we decided to translate the English-language version of the QLQ-C30 and its supplementary breast-cancer-specific instrument (QLQ-BR23) [22] into Persian (Iranian language) for the first time, for…”
MethodZubrod, C. G., Schneiderman, M., Frei, E., Brindley, C., Lennard Gold, G., Shnider, B., Oviedo, R., Gorman, J., Jones, R., Jonsson, U., et al. (1960) · Journal of Chronic Diseases · doi:10.1016/0021-9681(60)90137-5 · Cited by 1,034 · cited 1×
“Zero indicates that the patient is able to carry out all normal activities and 4, that the patient is completely disabled [24].”
BackgroundMeasuring Disease: A Review of Disease-Specific Quality of Life Measurement Scales
Bowling, A. (1995) · Research Repository (Kingston University London) · Cited by 731
Sprangers, M. A. G., Cull, A., Bjordal, K., Groenvold, M., Aaronson, N. K., & EORTC Study Group on Quality of Life (1993) · Quality of Life Research · doi:10.1007/bf00434800 · Cited by 514
Bowling, A. (1995) · Social Science & Medicine · doi:10.1016/0277-9536(95)00113-l · Cited by 509 · cited 1×
“Measuring quality of life in cancer patients is rapidly becoming more widespread, although some conceptual and methodological issues remain to be settled [7, 13, 18, 20].”
Background
Cited by
(2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-14 · Cited by 640
Self-citationMontazeri, A., Harirchi, A. M., Shariati, M., Garmaroudi, G., Ebadi, M., & Fateh, A. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-66 · Cited by 606
Self-citationPommier, P., Chabaud, S., Lagrange, J. L., Richaud, P., Lesaunier, F., Le Prise, E., Wagner, J. P., Hay, M. H., Beckendorf, V., Suchaud, J. P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.5171 · Cited by 340
Montazeri, A., Vahdaninia, M., Harirchi, I., Ebrahimi, M., Khaleghi, F., & Jarvandi, S. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-330 · Cited by 283
“The psychometric properties of the Iranian version of both questionnaires are well documented [10,11].”
Self-citationWhat do predict anxiety and depression in breast cancer patients? A follow-up study
Vahdaninia, M., Omidvari, S., & Montazeri, A. (2010) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-009-0068-7 · Cited by 275
“The psychometric properties of the Iranian version of EORTC QLQ-C30 questionnaire are confirmed [24].”
MethodSelf-citationArndt, V., Stegmaier, C., Ziegler, H., & Brenner, H. (2006) · Cancer · doi:10.1002/cncr.22274 · Cited by 164
Xie, L., Xu, J., Sun, X., Guo, W., Gu, J., Liu, K., Zheng, B., Ren, T., Huang, Y., Tang, X., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000798 · Cited by 145
Klein, J., Livergant, J., & Ringash, J. G. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.01.015 · Cited by 124
“These instruments are all available and validated in multiple languages [15–22].”
BackgroundMontazeri, A., Harirchi, I., Vahdani, M., Khaleghi, F., Jarvandi, S., Ebrahimi, M., & Haji‐Mahmoodi, M. (2000) · Quality of Life Research · doi:10.1023/a:1008918310251 · Cited by 128
“This paper reports data on the reliability and validity of the Iranian version of the EORTC QLQ-BR23 and the data relating to the QLQ-C30 questionnaire can be found elsewhere [6].”
MethodSelf-citationRohani, C., Abedi, H.-A., Omranipour, R., & Langius-Eklöf, A. (2015) · Health and Quality of Life Outcomes · doi:10.1186/s12955-015-0229-1 · Cited by 106
“The low coefficients for these scales could be due to the low number of items on these scales [61], and this is consistent with some previous findings as well [13,59].”
ResultFactors predicting the use of complementary and alternative therapies among cancer patients in Iran
MONTAZERI, A., SAJADIAN, A., EBRAHIMI, M., HAGHIGHAT, S., & HARIRCHI, I. (2007) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2006.00722.x · Cited by 103
Self-citationMontazeri, A., Tavoli, A., Mohagheghi, M. A., Roshan, R., & Tavoli, Z. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-39 · Cited by 102
“Validity (performing knowngroups comparison analysis), also showed that all the functional and symptom scales discriminated between subgroups of patients differing in clinical status as defined by their performance status and disease stage [13].”
ResultSelf-citationDepression and quality of life in cancer patients with and without pain: the role of pain beliefs
Tavoli, A., Montazeri, A., Roshan, R., Tavoli, Z., & Melyani, M. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-177 · Cited by 97
“The validation study of the Iranian version of the EORTC QLQ-C30 showed that it is a reliable and valid measure of quality of life in cancer patients [22].”
MethodSelf-citationRohani, C., Abedi, H., Sundberg, K. K., & Langius‐Eklöf, A. (2015) · Health and Quality of Life Outcomes · doi:10.1186/s12955-015-0392-4 · Cited by 103
“Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, et al. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): translation and validation study of the Iranian version.”
MethodInfluentialKhodabakhshi, A., Seyfried, T. N., Kalamian, M., Beheshti, M., & Davoodi, S. H. (2020) · Nutrition Journal · doi:10.1186/s12937-020-00596-y · Cited by 88
Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients
Cankurtaran, E. Ş., Özalp, E., Soygür, H., OZER, S., Akbıyık, D. İ., & Bottomley, A. (2007) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2007.00827.x · Cited by 110
“Our results indicate that the reliability analysis for multi-item subscales yielded very similar results to the Western, Iranian, Korean and Japanese studies (Aaronson et al. 1993; Kobayashi et al. 1998; Montazeri et al. 1999; Yun et al. 2004).”
BackgroundResultSpiritual needs and quality of life of patients with cancer
Tirgari, B., Forouzi, M., Safarizadeh, M. H., & Jahani, Y. (2017) · Indian Journal of Palliative Care · doi:10.4103/ijpc.ijpc_53_17 · Cited by 86
Depression, anxiety, and health related quality of life among colorectal cancer survivors
Aminisani, N., Nikbakht, H., Jafarabadi, M. A., & Shamshirgaran, S. M. (2017) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2017.01.12 · Cited by 87
“A Persian version of the two questionnaires which had already been validated prior to the study were also used in this survey (20,21).”
MethodLuo, N., Fones, C. S. L., Lim, S. E., Xie, F., Thumboo, J., & Li, S. (2005) · Quality of Life Research · doi:10.1007/s11136-004-4782-z · Cited by 90
Zhao, H., & Kanda, K. (2004) · Journal of Epidemiology · doi:10.2188/jea.14.193 · Cited by 78
Sharif, F., Abshorshori, N., Tahmasebi, S., Hazrati, M., Zare, N., & Masoumi, S. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-74 · Cited by 85
Tantawy, S. A., Abdelbasset, W. K., Nambi, G. S., & Kamel, D. M. (2019) · Integrative Cancer Therapies · doi:10.1177/1534735419847276 · Cited by 85
“The symptom scores ranged from 100 to 0, and lower scores indicated better condition.(29) Patient assessments were done in a different room (not treatment room) by an experienced collaborative blinded physiotherapist who was not part of the study.”
BackgroundWeekly administration of docetaxel for symptomatic metastatic hormone‐refractory prostate carcinoma
Gravis, G., Bladou, F., Salem, N., Macquart‐Moulin, G., Serment, G., Camerlo, J., Genre, D., Bardou, V., Maraninchi, D., & Viens, P. (2003) · Cancer · doi:10.1002/cncr.11687 · Cited by 74
Char, S., Bloom, J. A., Erlichman, Z., Jonczyk, M. M., & Chatterjee, A. (2021) · The Breast Journal · doi:10.1111/tbj.14186 · Cited by 66
Erku, D. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/2809875 · Cited by 66
Cordova, L. Z., Hunter‐Smith, D. J., & Rozen, W. M. (2019) · Gland Surgery · doi:10.21037/gs.2019.07.02 · Cited by 66
Depression and the use of complementary medicine among breast cancer patients
Montazeri, A., Sajadian, A. S., Ebrahimi, M., & Akbari, M. E. (2004) · Supportive Care in Cancer · doi:10.1007/s00520-004-0709-z · Cited by 65
Self-citationQuality of Life in Patients with Gynecological Cancers: A Web-Based Study
Shirali, E., Yarandi, F., Ghaemi, M., & Montazeri, A. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.7.1969 · Cited by 67
“The psychometric properties of the Iranian version are well document (Montazeri et al., 1999).”
BackgroundSelf-citationAbu‐Saad, H. H., Sagherian, K., & Tamim, H. (2012) · Quality of Life Research · doi:10.1007/s11136-012-0261-0 · Cited by 67
“Similar results were found in other studies reporting low Cronbach’s alphas in cognitive functioning and nausea and vomiting [11, 22], and social functioning at prediagnosis and follow-up assessments [23].”
ResultNejjari, C., Fakir, S. E., Bendahhou, K., Rhazi, K. E., Abda, N., Zidouh, A., Benider, A., Errihani, H. H., & Bekkali, R. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-228 · Cited by 63
“The average time required to complete the questionnaire was similar to that reported in earlier studies [4,15,17,18].”
MethodResultBahrami, T., Rejeh, N., Heravi‐Karimooi, M., Vaismoradi, M., Tadrisi, S. D., & Sieloff, C. L. (2017) · International Journal of Nursing Practice · doi:10.1111/ijn.12601 · Cited by 64
“The reliability and validity of the Iranian version of the HADS was assessed (Montazeri et al., 1999).”
Silpakit, C., Sirilerttrakul, S., Jirajarus, M., Sirisinha, T., Sirachainan, E., & Ratanatharathorn, V. (2006) · Quality of Life Research · doi:10.1007/s11136-005-0449-7 · Cited by 82
“Even the EORTC was developed in western culture, it was found to be suitable when using in eastern countries such as China [4], Taiwan [5], Japan [6], Korea [7], Singapore [8] and Iran [9].”
BackgroundHoopman, R., Muller, M. J., Terwee, C. B., & Aaronson, N. K. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.047 · Cited by 54
Johnson, F. R., Hauber, B., Osoba, D., Hsu, M., Coombs, J. H., & Copley‐Merriman, C. (2006) · Quality of Life Research · doi:10.1007/s11136-005-0581-4 · Cited by 50
Sadighi, S., Mohagheghi, M. A., Montazeri, A., & Sadighi, Z. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-274 · Cited by 47
Self-citationAmeri, H., Yousefi, M., Yaseri, M., Nahvijou, A., Arab, M., & Sari, A. A. (2018) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2018.1517046 · Cited by 47
Validation study of a quality of life (QOL) questionnaire for use in Iran.
Safaee, A., & Dehkordi, B. M. (2007) · PubMed · Cited by 61
Health-related quality of life among breast cancer patients in Lebanon
Abu‐Saad, H. H., & Abboud, S. (2012) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2011.11.003 · Cited by 43
“…social functioning; three symptom scales (fatigue, pain, and nausea and vomiting), and a global health and quality of life scale (Aaronson et al., 1988, 1993); EORTC-QLQ C-30 is a valid and reliable tool (Aaronson et al., 1993; Hagelin et al., 2006; Montazeri et al., 1999; Sprangers et al., 1998).”
MethodRahmani, S., Talepasand, S., & Ghanbary-Motlagh, A. (2014) · Europe PMC (PubMed Central) · Cited by 42
Mohammadi, S., Sulaiman, S., Poh, B. K., Amani, R., & Hosseini, S. M. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.1.481 · Cited by 51
“EORTC QLQ-C30 Version 3.0 (Aaronson et al., 1993) validated in Persian language by Montazeri et al. (1999) and its breast cancer module (QOL-BR23) was validated in Persian language by Montazeri et al. (2000) which used to assess QOL among breast cancer survivors.”
MethodInfluentialThe effect of rehabilitation on quality of life in female breast cancer survivors in Iran
Poorkiani, M., Abbaszadeh, A., Hazrati, M., Jafari, P., Sadeghi, M., & Mohammadianpanah, M. (2010) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/0971-5851.76190 · Cited by 39
A Prospective longitudinal evaluation of quality of life after abdominoperineal resection
Gervaz, P., Bucher, P., Konrad, B., Morel, P., Beyeler, S., Lataillade, L., & Allal, A. S. (2007) · Journal of Surgical Oncology · doi:10.1002/jso.20910 · Cited by 41
Urdániz, J. I. A., Iturre, E. V., de la Vega, F. A., Dominguez, M. A., Milagro, N. L., Burgaleta, A. M., López, E. M., Rojano, P. R., & Aguillo, M. M. (2008) · Archivos Españoles de Urología · doi:10.4321/s0004-06142008000800017 · Cited by 40
Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in Colorectal Cancer Patients
Ameri, H., Yousefi, M., Yaseri, M., Nahvijou, A., Arab, M., & Sari, A. A. (2019) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-019-00229-6 · Cited by 39
“0 and the QLQ-CR29 have already been validated for use in Iran with a sample of breast and colorectal cancer patients, respectively [22, 23].”
MethodSong, W.-C., Qiao, X., & Gao, X. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0724-1 · Cited by 36
“In the EORTC QLQ-STO22, the QOL is lower when the scores for each category are higher [15–17].”
BackgroundMalihi, Z. A., Kandiah, M., Chan, Y. M., Hosseinzadeh, M., Azad, M. S., & Yeganeh, M. Z. (2013) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12043 · Cited by 35
“Cronbach’s alpha results for multi-item scales of QOL-C30 were similar to those of Montazeri et al. (1999), ranging from 0.41 to 0.87 before and after chemotherapy.”
MethodInfluentialKhazaee-Pool, M., Nadrian, H., & Pasha, N. (2012) · Gastroenterology Nursing · doi:10.1097/sga.0b013e3182605f86 · Cited by 35
Hatam, N., Ahmadloo, N., Kiadaliri, A., Bastani, P., & Askarian, M. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-010-1609-8 · Cited by 34
“[11] and Haji Mohammadi et al.”
Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
Khoshnevisan, A., Yekaninejad, M. S., Ardakani, S. K., Pakpour, A. H., Mardani, A., & Aaronson, N. K. (2012) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-10-54 · Cited by 35
“The QLQ-BN20 was administered together with the QLQ-C30 to 194 patients diagnosed with primary brain cancer.”
MethodInfluentialAlawadhi, S. A., & OHAERI, J. U. (2010) · Annals of Saudi Medicine · doi:10.4103/0256-4947.67083 · Cited by 34
Relationship between Spiritual Health and Quality of Life in Patients with Cancer
Mohebbifar, R., Pakpour, A. H., Nahvijou, A., & Sadeghi, A. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.16.7321 · Cited by 39
“The European Organization for Research and Treatment of Cancer has confirmed the validity and reliability of this questionnaire and Montazeri et al. then reported a validity of 76% and a reliability of 93% for it in Iran (Montazeri et al., 1999).”
BackgroundMethodNaderi, M., Kordestani, H., Sahebi, Z., Zare, V. K., Amani-Shalamzari, S., Kaviani, M., Wiskemann, J., & Shamsi, M. M. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01671-8 · Cited by 33
“The validity and reliability of this questionnaire were confirmed in the Iranian cancer population [33].”
BackgroundBaumann, R., PÜTZ, C., Röhrig, B., Höffken, K., & Wedding, U. (2009) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2008.00975.x · Cited by 30
Bouya, S., Koochakzai, M., Rafiemanesh, H., Balouchi, A., Taheri, S., Badakhsh, M., & Didehvar, M. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4750-x · Cited by 30
Translating clinical tools in nursing practice
Dunckley, M., Hughes, R., Addington-Hall, J. M., & Higginson, I. J. (2003) · Journal of Advanced Nursing · doi:10.1046/j.0309-2402.2003.02821.x · Cited by 28
Abdollahi, A., Alsaikhan, F., Nikolenko, D. A., Al-Gazally, M. E., Mahmudiono, T., Allen, K., & Abdullaev, B. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04470-5 · Cited by 27
Quality of life in patients with colorectal cancer in Iran
Akhondi‐Meybodi, M., Akhondi-Meybodi, S., Vakili, M., & Javaheri, Z. (2016) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2016.06.001 · Cited by 27
Quality of life, religious attitude and cancer coping in a sample of Iranian patients with cancer.
Vahid, M. K. A., Nasr-Esfahani, M., Esfeedvajani, M. S., Naji, H., Shojaei, M. R., Masoumeh, Y. M., & Goushegir, S. A. (2011) · PubMed Central · Cited by 27
Yousefi, M., Nahvijou, A., Sari, A. A., & Ameri, H. (2021) · Value in Health Regional Issues · doi:10.1016/j.vhri.2020.06.006 · Cited by 30
Iravani, K., Jafari, P., Akhlaghi, A., & Khademi, B. (2018) · Health and Quality of Life Outcomes · doi:10.1186/s12955-018-1012-x · Cited by 28
Moradian, S., Shahidsales, S., Nasiri, M. R. G., Pilling, M. A., Molassiotis, A., & Walshe, C. (2013) · European Journal of Cancer Care · doi:10.1111/ecc.12147 · Cited by 26
Chan, A., Lew, C., Wang, X. J., Ng, T. R. D., Chae, J., Yeo, H. L., Shwe, M., & Gan, Y. X. (2018) · Health and Quality of Life Outcomes · doi:10.1186/s12955-018-0846-6 · Cited by 26
Patoo, M., Allahyari, A. A., Moradi, A., & Payandeh, M. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.9.3799 · Cited by 25
Taxane-induced peripheral neuropathy and quality of life in breast cancer patients
Salehifar, E., Janbabaei, G., Alipour, A., Tabrizi, N., & Avan, R. (2020) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155219898511 · Cited by 24
“The validity of the Iranian version of the EORTC QLQ-C30 has been demonstrated previously.(15) This questionnaire concludes five functional scales (physical, role, cognitive, emotional, and social), three symptom scales (fatigue, pain, and nausea and vomiting), a global health status/ QOL scale, and single-item scales…”
MethodSymptom Prevalence and Management of Cancer Patients in Lebanon
Abu‐Saad, H. H., Abboud, S., & Doumit, M. A. A. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2011.10.019 · Cited by 28
Hosseini, A. M., Rezaei, M., Bahrami, M., Abbasi, M., & Hariri, H. (2017) · PubMed Central · doi:10.4103/1735-9066.208157 · Cited by 24
“The Persian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ‐C30) was used for QOL assessment.[27] This 30‐item questionnaire consists of a functional scale (physical, role, emotional cognitive, and social functioning), symptom scale (fatigue, nausea, a…”
MethodZareifar, S., Farahmandfar, M. R., Cohan, N., Modarresnia, F., & Haghpanah, S. (2011) · The Indian Journal of Pediatrics · doi:10.1007/s12098-011-0483-0 · Cited by 24
Evaluation of quality of life in patients with oral cancer after mandibular resection
Davudov, M. M., Harirchi, I., Arabkheradmand, A., Garajei, A., Mahmoodzadeh, H., Shirkhoda, M., Motiee‐Langroudi, M., Mirzajani, Z., Zebardast, J., & Montazeri, A. (2019) · Medicine · doi:10.1097/md.0000000000017431 · Cited by 23
“The psychometric properties of the Iranian version of the questionnaire are well documented.([8])”
BackgroundSelf-citationAlami, Y. E., Essangri, H., Majbar, M. A., Boutayeb, S., Benamr, S., Malki, H. O. E., & Souadka, A. (2021) · BMC Cancer · doi:10.1186/s12885-021-07793-w · Cited by 23
“As this average response time is similar to those reported in other validation studies, the Moroccan version can be adequately used in other clinical studies [17, 18].”
ResultChar, S., Bloom, J. A., Erlichman, Z., Jonczyk, M. M., Chatterjee, A., & Guo, L. (2022) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000009616 · Cited by 20
Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran
Moradi, N., Poder, T. G., Safari, H., Mojahedian, M. M., & Ameri, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1052155 · Cited by 23
Bahrami, T., Rejeh, N., Heravi‐Karimooi, M., Tadrisi, S. D., & Vaismoradi, M. (2019) · International Journal of Therapeutic Massage & Bodywork Research Education & Practice · doi:10.3822/ijtmb.v12i3.429 · Cited by 18
Hashemi, F. H., Atashzadeh‐Shoorideh, F., Oujian, P., Mofid, B., & Bazargan, M. (2021) · Nursing Open · doi:10.1002/nop2.808 · Cited by 18
Quality of Life in Women with Cancer and Its Influencing Factors
Sheikhalipour, Z., Ghahramanian, A., Fateh, A., Ghiahi, R., & Onyeka, T. C. (2019) · Journal of Caring Sciences · doi:10.15171/jcs.2019.002 · Cited by 17
Pedraza, R. S., & Valderamar, A. (2020) · Revista Colombiana de Cancerología · doi:10.35509/01239015.128 · Cited by 20
Sadighi, S., Montazeri, A., Sedighi, Z., Mohagheghi, M. A., & Froutan, H. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-305 · Cited by 17
“The psychometric properties of the Iranian version of the EORTC QLQ-C30 are well documented [7].”
Self-citationEffects of a Lifestyle Interventions Program on Quality of Life in Breast Cancer Survivors
Ghavami, H. (2017) · International Journal of Hematology and Oncology · doi:10.4999/uhod.171734 · Cited by 17
The Relationship between Coping Strategies and Quality of Life in Women with Breast Cancer
Monfared, E. D., Radfar, S., Mohseny, M., & Hosseini-Dastjerdi, Z. S. (2023) · International journal of body, mind and culture · doi:10.22122/ijbmc.v10i2.402 · Cited by 16
Smith, A. B., Cocks, K., Taylor, M. J., & Parry, D. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.03.004 · Cited by 16
Jayasekara, H., Rajapaksa, L. C., & Aaronson, N. K. (2008) · Quality of Life Research · doi:10.1007/s11136-008-9345-2 · Cited by 18
Zahid, N., Martins, R. S., Zahid, W., Khalid, W., Azam, I., Bhamani, S. S., Asad, N., Ahmad, K., Jabbar, A. A., Shamim, M. S., et al. (2021) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-021-00354-6 · Cited by 16
Solooki, S., Ardestani, S. M. M., Mahdaviazad, H., & Kardeh, B. (2017) · MUSCULOSKELETAL SURGERY · doi:10.1007/s12306-017-0511-y · Cited by 18
Haghighat, S., Montazeri, A., Zayeri, F., Ebrahimi, M., & Weiss, J. (2018) · Health and Quality of Life Outcomes · doi:10.1186/s12955-018-0958-z · Cited by 16
Self-citationRoustaee, S., Rashtabadi, O. R., Tirgari, B., Jahani, Y., & Tahmasebi, S. (2022) · Disability and Rehabilitation · doi:10.1080/09638288.2022.2148296 · Cited by 15
“These two questionnaire have been validated in Iran by Montazeri et al. and their items and scoring were explained there [23,24].”
MethodHatam, N., Askarian, M., Javan‐Noughabi, J., Ahmadloo, N., & Mohammadianpanah, Μ. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.18.8265 · Cited by 14
“Also in Iran, it was considered as an appropriate tool for measuring the quality of life in cancer patients with high reliability and validity, as mentioned by Montazeri et al (Montazeri et al., 1999).”
MethodHassani Alimolk, F., McDonald, F. E. J., Asghari‐Jafarabadi, M., Ahmadi, F., Zenoozian, S., Lashkari, M., & Patterson, P. (2024) · Psycho-Oncology · doi:10.1002/pon.6339 · Cited by 13
“27 Further details about each measure are provided below.”
BackgroundSalido‐Bueno, B., Gil-Hernández, E., Rueda‐Ruzafa, L., Gómez‐Chica, P., Román, P., & Cardona, D. (2024) · Nutrition Bulletin · doi:10.1111/nbu.12693 · Cited by 13
Asadi‐Lari, M., Pishkuhi, M. A., Almasi‐Hashiani, A., Safiri, S., & Sepidarkish, M. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2510-y · Cited by 13
Yekaninejad, M. S., Pakpour, A. H., Tadakamadla, J., Kumar, S., Mousavie, S. H., Fridlund, B., Bottomley, A., & Aaronson, N. K. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2468-9 · Cited by 14
“The EORTC QLQ-C30 has been translated into several languages including Persian and has been found to be highly valid and reliable [18].”
MethodBaljani, E., Kazemi, M., Amanpour, E., & Tizfahm, T. (2014) · Basic & Clinical Cancer Research · Cited by 23
Zhou, L., Zheng, W., Huang, S., & Yang, X. (2022) · Discover Oncology · doi:10.1007/s12672-022-00606-x · Cited by 12
“EORTC QLQC-30 and H&N35 questionnaire contains dozens of questions, and uses a 4-point Likert scale to describe the condition as ‘none’, ‘a bit’, ‘quite a bit’, and ‘a lot’ [30].”
Tavoli, A., Tavoli, Z., & Montazeri, A. (2019) · International Journal of Cancer Management · doi:10.5812/ijcm.94568 · Cited by 14
“This questionnaire has been translated and validated for use by Iranian patients and its psychometric properties have been well documented (17).”
MethodSelf-citationBayati, M., Molavynejad, S., Norollah, T., & Cheraghian, B. (2019) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2019.20.11.3457 · Cited by 12
“The reliability and validity of QLQ-C30 questionnaire have been evaluated by Iranian researchers, showing a suitable validity and reliability (73-96%) (Montazeri et al., 1999; Safaee and Moghim Dehkordi, 2007).”
BackgroundAhmadzadeh, A., Yekaninejad, M. S., Saffari, M., Pakpour, A. H., & Aaronson, N. K. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.1.255 · Cited by 11
“The Persian version of the EORTC-C30 has been found to be valid and reliable when used with Iranian patients with cancer (Montazeri et al., 1999).”
MethodKiadaliri, A., Bastani, P., & Ibrahimipour, H. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.3.941 · Cited by 11
Response shift in quality of life assessment among cancer patients: A study from Iran
Hosseini, B., Nedjat, S., Zendehdel, K., Majdzadeh, R., Nourmohammadi, A., & Montazeri, A. (2017) · Medical Journal of the Islamic Republic of Iran · doi:10.14196/mjiri.31.120 · Cited by 10
“The validity and reliability of this questionnaire have already been evaluated in Iran (24).”
BackgroundSelf-citationConceptual structure of the Taiwan Chinese version of the EORTC QLQ-C30
Huang, C., Tu, S., Lien, H.-H., Huang, C.-S., Wang, P., & Chie, W. (2015) · Quality of Life Research · doi:10.1007/s11136-014-0913-3 · Cited by 11
“conducted in mainland China, Japan, Korea, Singapore, Iran, India, Thailand, and Taiwan [8, 36–42].”
Health-related quality of life after chemotherapy cycle in breast cancer in Iran
Bastani, P., & Kiadaliri, A. (2010) · Medical Oncology · doi:10.1007/s12032-010-9714-x · Cited by 10
“Reliability and validity of the questionnaire in Persian language was known suitable, and it was distinguished as an appropriate tool for measuring the quality of life in breast cancer [ 11 ].”
Basiri, A., Zahir, M., Soleimani, M., Khoshdel, A., Tabibi, A., Imen, M. S., Soheilipour, A., Golshan, S., Balafkan, M., Parvin, M., et al. (2023) · Urologia Journal · doi:10.1177/03915603231209090 · Cited by 9
Davudov, M. M., Harirchi, I., Amiraliyev, N., Mehtiyeva, E., Mirzajani, Z., Amiraliyev, K., Rustamli, N., Zebardast, J., & Montazeri, A. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.1.267 · Cited by 9
“org) and currently it is available in Persian (Montazeri et al., 1999), Turkish (Guzelant et al.”
BackgroundResultInfluentialSelf-citation
Metadata
- Authors
- Montazeri, A., Harirchi, I., Vahdani, M., Khaleghi, F., Jarvandi, S., Ebrahimi, M., & Haji-Mahmoodi, M.
- Venue
- Supportive Care in Cancer
- Published
- 1999-10-11
- Volume
- 7
- Issue
- 6
- Pages
- 400-406
- ISSN
- 0941-4355 (ISSN-L)
- 1433-7339
- OpenAlex
- W2074668580
- Cited by
- 176
- References
- 17
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 10 · 2023: 8 · 2022: 13 · 2021: 14 · 2020: 12 · 2019: 10 · 2018: 8 · 2017: 10 · 2016: 4 · 2015: 9 · 2014: 9 · 2013: 7 · 2012: 12
- FWCI
- 0.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Supportive Care in Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Nursing › Research and Theory › Health Education and Validation
- Keywords
- EORTC QLQ-C30, quality of life, breast cancer, Persian translation, cross-cultural adaptation, psychometric validation, reliability statistics, known-groups comparison, cancer patients, Iranian patients
- MeSH terms
- Activities of Daily Living, Adult, Aged, Aged, 80 and over, Analysis of Variance, Breast Neoplasms, Clinical Trials as Topic, Cognition, Emotions, Female, Follow-Up Studies, Humans, Iran, Language, Middle Aged, Neoplasm Staging, Quality of Life, Surveys and Questionnaires, Role, Social Adjustment, Reproducibility of Results, Outcome Assessment, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.